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Criteria for Enrolling Dementia Patients in Hospice 
Daniel] Luchins, MD,' Patricia Hanrahan, PhD,* and Kathleen Murphy, MDt 
OBJECTIVE: Because survival time varies greatly, it is diffi- 
cult for dementia patients to meet a key criterion for eligibil- 
ity for the Medicare hospice benefit: a 6-month survival time. 
We have developed criteria for the Medicare hospice benefit 
that include the characteristics of advanced dementia and 
related medical complications. The purpose of the study was 
to determine survival time among dementia patients who met 
these criteria. Additionally, because the National Hospice 
Organization (NHO) developed its own guidelines while the 
study was in progress, we retrospectively examined the ap- 
plication of these guidelines to our sample. 
DESIGN Two cohorts of hospice patients were studied lon- 
gitudinally, each for 2 years. 
SETTING: Nine Midwestern hospice programs. 
PARTICIPANTS: Forty-seven patients were enrolled in 
home hospice and institutional hospice settings. 
MEASUREMENTS: Survival time consisted of the number 
of days between enrollment in the hospice program and death 
or the end of the study. Other measures included Activities of 
Daily Living, ratings of Appetite, Nourishment, and Mobil- 
ity, Functional Assessment Staging (FAST), a Medical Com- 
plications Checklist, and a care plan concerning the use of 
medications for acute illness. 
RESULTS: Our hospice enrollment criteria predicted a me- 
dian survival time of 4 months and a mean survival time of 
6.9 months; 38% of patients survived for more than 6 
months. FAST scores and Mobility ratings were significantly 
related to survival time. However, 41 'YO could not be scored 
on the FAST as their disease progression was not ordinal. 
Among patients who could be scored on the FAST and who 
had reached Stage Seven C, their mean survival time was 3.2 
months compared with 18 months among those who could 
be scored and had not reached this stage and 8.6 months 
among patients whose disease progression was not ordinal, 
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P < .001. When the palliative care plans were examined, less 
aggressive care plans resulted in shorter survival times, P < 
.01. 
CONCLUSION Our hospice enrollment criteria identified a 
group with a median survival time of 4 months and a mean 
survival time of 6.9 months. Using NHO criteria relying on 
the FAST allows the identification of a subgroup with very 
high mortality and a short time until death. Although the 
FAST can identify a subgroup of appropriate candidates for 
hospice, sole reliance on this measure might decrease access 
to hospice care for many dementia patients. J Am Geriatr SOC 
45:1054-1059,1997. 
nd-stage dementia is a significant clinical problem for E which alternative modes of care are needed. Many pa- 
tients with end stage dementia are ideal candidates for hos- 
pice because their prognosis is terminal and aggressive med- 
ical treatment is rarely preferred.'-' Palliative care is intended 
to relieve symptoms, to control pain, and, thereby, to ease 
death rather than to prolong life. These goals apply to end- 
stage dementia patients, who often die of medical complica- 
tions of the disease such as aspiration pneumonia. Reports of 
pilot hospice programs for dementia patients suggest that this 
approach is feasible3" as well as ethical.'~6-8 In one survey, 
90% of family and professional caregivers of dementia pa- 
tients viewed hospice care as appropriate for the end stages of 
the disease.' Yet only 13% were aware of hospices that 
served dementia patients compared with. 87% who were 
aware of hospice services for cancer patients. This suggests 
unmet need. 
For editorial comment, see p. 1147 
Lack of utilization of hospice care in advanced dementia 
was further documented in our national survey of 1184 
hospice programs.' Fewer than 1 % of hospice patients had a 
primary diagnosis of dementia. A study that examined Medi- 
care beneficiaries in hospice had similar findings; 1.5% of 
hospice patients had dementia as a primary diagnosis." 
Among hospice staff from our national survey, 80% viewed 
difficulties in predicting the survival time of dementia patients 
as a major problem in their efforts to serve these patients. 
Eligibility for the Medicare hospice benefit requires a prog- 
nosis of death within 6 months. However, survival time in 
Alzheimer's disease and vascular dementia is highly variable 
and can range from 2 to 10 years." Recent evidence has 
confirmed that dementia patients in hospice have a signifi- 
cantly longer survival time than those with other diagnoses, 
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with 35% surviving longer than 6 months.” Yet relatively 
little research has been conducted on the development of 
empirically based standards for enrolling patients with end- 
stage dementia in hospice, aside from the pioneering studies 
of Volicer and his colleagues in an institutional ho~p ice .~ , ’~  
In a study of a home-based hospice, we have developed 
enrollment criteria that identified a group of dementia pa- 
tients whose median survival time was 5 months, with a mean 
of 7 months (Table The main purpose of this research 
was to expand the study to institutional hospice settings as 
well as to replicate our findings with home hospice patients. 
A second purpose concerns the analysis of the National 
Hospice Organization (NHO) guidelines. Since these studies 
began, NHO guidelines have been developed to assist pri- 
mary care physicians to identify “patients with non- 
oncological disease who may be appropriate for admission to 
a hospice program. . . under the MedicareIMedicaid Hospice 
Benefit.”13 Medical guidelines for assessing prognosis were 
developed for other terminal illnesses in addition to demen- 
tia, for example, heart disease and pulmonary disease. It is 
anticipated that a revised version will include more guidelines 
for other end-stage conditions. The guidelines are designed 
not to function as strict admission criteria but to assist 
physicians in making clinical judgments. With regard to 
dementia, the NHO guidelines parallel our own but with the 
addition of a more detailed description of medical complica- 
tions and the suggestion that Stage Seven C of Functional 
Assessment Staging may be an appropriate cutoff point for 
enrollment (Table 2).l39l4 Using our experience with the 
patients in our study, we have examined the implications of 
these refinements. 
Table 1. Hospice Enrollment Criteria for End-Stage 
Dementia Patients5 
Signs of very severe cognitive decline 
May have the following (if known) 
Low mental status scores (MSQ or MMSE less than or 
equal to 1) 
decline 
Incontinent 
Needs assistance with eating 
Needs assistance with walking 
Needs assistance with bathing and grooming 
Very limited speech or cannot communicate 
Unable to engage in purposeful activities 
All of the following impairments due to severe cognitive 
meaningfully 
Serious complications: Patient should have a current or 
recent history of one or more of the following 
impairments 




Severe urinary tract infection 
Decubitus ulcers 
Septicemia 
Other serious complications 
Table 2. NHO Medical Guidelines for Determining Prognosis 
in DementiaI3 
Functional assessment staging 
Patients who have reached the level of severity of 
dementia described here may have a prognosis of up 
to 2 years 
Staging Scale 
At or beyond Stage Seven of the Functional Assessment 
All of the following characteristics 
Unable to dress without assistance 
Unable to bathe properly 
Urinary and fecal incontinence 
Unable to speak or communicate meaningfully 
Unable to ambulate without assistance 
Presence of medical complications 
Comorbid conditions of sufficient severity to warrant 
Comorbid conditions associated with dementia 
medical treatment, documented within the past year 
Aspiration pneumonia 
Pyelonephritis or other upper urinary tract infection 
Septicemia 
Decubitus ulcers 
Difficulty swallowing food or refusal to eat, sufficiently 
severe that patient cannot maintain sufficient fluid 
and calorie intake to sustain life* 
enrollment cutoff (Appendix 1). At this stage, patients 
are usually 
course of the day, 
mobility. 
Stage Seven C of the FAST may be an appropriate 
Either mute or limited to a single intelligible word in the 
Dependent in all Activities of Daily Living, including 




Enrollment criteria developed for the study consisted of 
advanced dementia and a history of medical complications 
during the year before enrollment (Table 1). Patients were 
eligible for hospice if they were severely demented, with very 
low mental status, needed assistance in most Activities of 
Daily Living, and were no longer able to communicate be- 
yond an occasional word or two. Patients were also required 
to have a recent history of complications typical of end-stage 
dementia, for example, aspiration pneumonia, which causes 
swallowing problems. Patients who fit the criteria were en- 
rolled in the following two cohorts: (1) Meridian Hospice 
between 11/1/90 and 10/31/92 (n = 11) and (2) nine Mid- 
western hospices between 4/1/93 and 3/31/95 (n = 36).  
Enrollment stopped 6 months before the end of each 2-year 
study period in order to allow for a 6-month follow-up 
period. No information is available about those patients who 
did not meet the criteria for admission to hospice although 
anecdotal evidence from hospice staff suggests that there were 
very few such patients. 
Settings 
Settings included the following nine Midwestern hos- 
pices: Meridian Hospice, Henry Ford Hospice, LaGrange 
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Memorial Hospice, Hospice of the North Shore, Horizon 
Hospice, Evangelical Health Service Hospice, West Towns 
VNS Hospice, VNA Hospice of Chicago, and the Hospice of 
Northeastern Illinois. Care was provided both at home and in 
nursing homes 
Measures 
After training in the use of the assessment instruments, 
hospice nurses collected patient information for the research 
staff. Because the hospice staffs were not accustomed to 
assessing the severity of dementia, a range of measures was 
used both to assist them in making this assessment and to 




Functional Impairment Levels 
Activities of Daily Living were rated on a 3-point scale 
(independent, needs assistance, totally dependent) from the 
Older Adults Resources and Services Instrument 
For example, with regard to eating, staff were 
asked to rate whether the patient could eat: (1) Without help 
(can feed self completely), (2) With some help (needs help 
cutting, etc.), or was (3) Completely unable to feed self. 
Medical Complications Checklist 
The Medical Complications Checklist (MCC) consisted 
of a list of common complications of end-stage dementia and 
when the problem occurred (current vs within the past year). 
Complications included swallowing problems, aspiration 
pneumonia, malnutrition, dehydration, decubitus ulcers, uri- 
nary tract infections, septicemia, seizures, fractures or broken 
bones, and deep vein thrombosis. The checklist was based on 
typical complications in advanced dementia according to 
physicians who responded to our previous survey.2 
Survival Time 
Survival Time consisted of the number of days between 
enrollment in the hospice program and the patient’s death, or 
if patients were not deceased, the number of days from 
enrollment until 10/31/92 for the first cohort and until 
3/31/95 for the second cohort. 
Additional Measures 
Additional Measures were used with the second cohort 
in order to further characterize factors influencing survival 
time: 
Pwformance Ratings 
These were drawn from a study of survival time among 
cancer patients in hospice: Appetite: 1 = normal to 5 = 
refuses fluid; Nourishment: 1 = heavy to 5 = extreme ca- 
chexia; and Mobility: 1 = normal to 5 = unable to turn in 
bed.” 
Level of Deterioration 
In the Functional Assessment Staging (FAST), the seven 
stages of previously dementia described in the Global Deteri- 
oration Scale (GDS) are further elaborated, and an ordinal 
progression is assumed (Appendix ).14,19 For example, Stage 
The Mental Status Quotient” was used to establish 
Seven is the most severe stage of dementia in the GDS. In the 
FAST, Stage Seven has been further subdivided to include six 
additional levels of disease progression in which the follow- 
ing deficits are assumed to occur in sequential order. At Stage 
Seven A, speech is limited to about six words in the course of 
a day. Next, at Stage Seven By intelligible vocabulary is 
limited to a single word in the course of the day. Subse- 
quently, at Stage Seven C, ambulatory ability becomes im- 
paired, and physical assistance is needed to walk. These 
impairments are followed by the loss of the ability to sit up 
(7D), to smile (7E), and to hold the head up (7F). 
Palliative Care Plan 
Hospice staff were asked to characterize the palliative 
care plan with regard to whether or not medications could be 
used for acute illnesses. 
Data Analysis 
Descriptive statistics were used to characterize demo- 
graphics, diagnosis, and survival time. Initially, univariate 
analysis was used to identify variables related to survival time 
(i.e., the correlation between performance ratings of mobility 
and survival time). Significant univariate relationships were 
then examined using multiple regression. With regard to 
NHO guidelines, a one-way ANOVA was used to compare 
survival times among those whose impairment was charac- 
teristic of Stage Seven C of the FAST, those who had not yet 
reached Stage Seven C, and those who could not be scored 
(see results for further discussion of this issue). Additionally, 
the combined effect of the patient’s care plan and status on 
the FAST was examined using a two-factor ANOVA. 
RESULTS 
Subjects 
orty-seven patients were enrolled in hospice care. The 
majority were women (70%). Their average age was 84 
(SD = 9.2). The majority (66%) were white (66%), and the 
remainder were black. Most had Alzheimer’s disease (71 YO). 
The remainder had vascular disease (9”/), a mixed dementia, 
usually vascular disease and Alzheimer’s disease (6%), Par- 
kinson’s disease (6%), or an unspecified dementia (8%). As 
per the enrollment criteria, all clients were severely impaired 
in their capacity to perform Activities of Daily Living (ADL) 
and had medical complications related to their dementia. 
Eighty-six percent had more than one medical complication. 
The majority had swallowing problems (72%). Decubitus 
ulcers also occurred frequently (70%). Aspiration pneumo- 
nia was common (55%), as were dehydration (57%), malnu- 
trition (SO%) ,  and urinary tract infections (37%). The pa- 
tients’ cognitive impairments were so severe that most were 
unable to participate in tests of mental status. The severity of 
the dementia corresponded to Stage Seven on the Global 
Deterioration Scale for all but one of the patients, who was in 
Stage Six E of the FAST.I4 
Median Survival Time 
Among the 47 patients, median survival time was 4 
months, with an average of 6.9 months (SD = 7.3 months); 
18 (38%) survived longer than 6 months. The 37 deceased 
patients from both cohorts had a mean survival time of 4.5 
months (SD = 6.5 months). The average survival time for the 
10 patients (21%) who were still alive was 15.7 months 
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(SD = 6.5 months). Patient characteristics such as demo- 
graphics and diagnosis were not significantly related to their 
survival time. There were no significant differences in survival 
time between patients receiving hospice at home (n = 22) and 
those receiving institutional hospice (n = 25). 
Predictors of Survival Time 
tients in the second cohort and are shown below. 
FAST Scores 
FAST scores were the strongest predictor, ( Y  = -.66, P < 
.01, n = 17). However, as discussed in a later section, many 
patients could not be scored. 
Performance Ratings 
Mobility impairments were highly correlated with sur- 
vival times ( Y  = -35, P < .001, n = 32), as were ratings of 
Appetite (Y  = - .47, P < .01, n = 29). Nourishment was not 
significant ( Y  = -.24, P = .19, n = 32). Functional impair- 
ment, as indicated by a total score on Activities of Daily 
Living, was also a strong predictor of survival time, ( Y  = 51 ,  
P < .01, n = 32). 
Medical Complications 
It was not possible to examine the role of specific comor- 
bidities, because most patients had more than one medical 
complication. However, the more complications the patients 
had, the shorter their survival time (Y = -41, P < .05, n = 29). 
Multivariate Analysis 
Multivariate analysis using multiple regression was con- 
ducted next to examine the relation between survival time 
and those predictors that were significant using univariate 
analysis. FAST scores were excluded from this analysis be- 
cause only 17 patients could be assessed (as discussed below). 
Only performance ratings of mobility remained significant in 
this analysis (F = 12.05, P < .01) and accounted for 28% of 
the variance in survival time (Adjusted R2 = 28.3, n’ = 29 to 
32). 
Predictors of survival time were examined only for pa- 
Problems in Using the FAST 
Because of time constraints, hospice staff were often 
unable to score the FAST, resulting in missing data for 19% 
of the second cohort (n = 7). A more important issue was that 
the assumption of an ordinal pattern of deterioration in the 
FAST proved to be inaccurate for 12 (41 %) of the 29 patients 
for whom this data was available (see Appendix). As a result, 
patients were next grouped in one of the following three 
categories: 
Patient Has Not Deteriorated to the Point of Reaching Stage 
Seven C or Greater (n = 5) 
Because the enrollment criteria suggested that patients 
have impairments in most or all ADLs, relatively few patients 
were in this group. One of these patients was at Stage Six E at 
intake, and the others were at Stage Seven A (n = 2) or Stage 
Seven B (n = 2). Although their verbal ability varied, the 
ability of these patients to walk was not impaired. The most 
striking finding was that all patients who could be scored in 
an ordinal fashion and who had not reached Stage Seven C 
were still surviving, with a mean survival time of 18.1 months 
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(SD = 7.1 months). All of these patients survived for more 
than 6 months. 
Patient Has Deteriorated to Stage Seven C or Greater 
(n = 12) 
The distinguishing characteristic of Stage Seven C is that, 
in addition to being limited to one word a day, ambulation is 
impaired. Mean survival time was 3.2 months (SD = 3.8 
months), and 11 of 12 patients (92%) were deceased. Two 
patients (17%) survived longer than 6 months. 
Patient Did Not Follow an Ordinal Progression (n = 12) 
The major difficulty in scoring the FAST in this group 
was their intelligible vocabulary had not decreased to one 
word a day. They could not, therefore, be coded as having 
progressed through Stage 7B, yet they had mobility impair- 
ments that would otherwise be characteristic of Stage 7C. 
Because their verbal impairment had not decreased to Stage 
Seven B (single woraday), their disease progression did not 
follow the sequence necessary for their assessment on the 
FAST. Within this group, the mean survival time was 8.6 
months (SD = 7 months); 11 of 12 patients (92%) were 
deceased but seven (58%) survived for more than 6 months. 
Survival times among these three groups differed signifi- 
cantly, P < .001 (ANOVA, F = 11.52). All pairwise compar- 
isons were also significant (Tukey-B test, P < .05). 
Palliative Care Plan 
When both FAST status and care plans were examined 
jointly, each had an effect on survival times (Table 3). Patients 
whose care plans called for the use of medication for acute 
illness had longer survival times than those without this 
provision, P < .01. There were no significant interactions. 
Limitation 
The small sample size limited multivariate analysis to the 
detection of large effect sizes. However, a large effect could be 
expected to have clinical significance in decision-making. 
Further research with a larger sample would be useful in 
Table 3. Survival Time: Effect of Palliative Care Plan and Patient 
Status on the FAST 
FAST Status* N = 25 Medications Medications 
Used for Not Used** 
Acute Illness Survival 
Survival Time Time 
More intact than 4 24.2 months 
Stage 7C (SD = .2) 
At or past 11 4 months 
Stage 7C (SD = 3.9) 
Not ordinal 10 14.9 months 
n = 2  
n = 6  
(SD = 6.2) 
n = 5  
17.5 months 
(SD = 2.8) 
n = 2  
2.6 months 
(SD = 4.3) 
n = 5  
5.2 months 
(SD = 3) 
n = 5  
ANOVA, F = 19.95, P < .001, 
“FAST Status, Main Effect, F = 25.6, P < ,001 
*“Use of Medications, Main Effect, F = 9.8, P < .O1 
1058 LUCHINS ET AL. SEPTEMBER 1997-VOL. 4.5, NO. 9 JAGS 
examining such issues as the relative importance of specific 
medical complications. 
DISCUSSION 
Our proposed hospice enrollment criteria identified a 
group of dementia patients with a median survival time of 4 
months; 38% survived past 6 months. These results are 
similar to the median survival of 2.5 months, with 35% living 
past 6 months, reported in a national study of Medicare 
hospice beneficiaries with a primary diagnosis of dementia." 
Although all the patients in our study were severely de- 
mented, there were still gradations of disability that our 
subsequent analysis shows are related to differing survival 
patterns. Patients who can be scored on the FAST and who 
have not reached Stage Seven C are unlikely to die within 6 
months. These patients do not appear to fit current require- 
ments for eligibility for hospice. In contrast, patients who can 
be scored on the FAST and who have reached Stage Seven C 
appear to be good candidates for hospice as most of those 
enrolled in the study died (11 of 12), with a mean survival 
time of 3.2 months, and only two patients (17%) survived 
more than 6 months. 
It is the patient whose disease progression was not ordi- 
nal who poses problems in using the FAST as an enrollment 
criterion. Problems in the assumption of an ordinal deterio- 
ration in dementia have been identified in our previous re- 
search using a sample from an Alzheimer's Disease Regis- 
try.20 The use of Stage Seven C as a cutoff is problematic 
because the lack of ordinality precluded using this measure 
for almost half of the patients in the second cohort. The 
non-ordinal patients had impaired mobility consistent with 
Stage Seven C but less severely impaired language function 
(i.e., greater than one word a day). 
It is not clear whether the Medicare policy for a 6-month 
prognosis refers to a median survival time, a mean survival 
time, or that 75%, or 85%, or 95% should be deceased at 
that point.21 Obviously, the more stringent the interpreta- 
tion, the more patients would lose access to hospice services. 
This issue is of particular importance for those severely 
demented patients whose disease progression did not follow 
an ordinal pattern. One possible way of dealing with these 
patients would be to assume that further deterioration, for 
instance, in their scant remaining language ability, might 
occur, and that hospice admission could be delayed until this 
deterioration took place. They would then be at Stage Seven 
C, regardless of initial ordinality. Inasmuch as our study did 
not measure deterioration on the FAST over time, we cannot 
analyze this possibility directly. Because the FAST was only 
available at  hospice enrollment, we have instead examined 
how long these patients survived in hospice in order to 
estimate what proportion would have survived if hospice 
admission were delayed for varying time periods in order to 
reevaluate their deterioration. Within 1 month of hospice 
enrollment one such patient died (8Yo of this group). By the 
third month of hospice care, another three patients died 
(25%); one more died in the fourth month for a total of five or 
42% within 4 months of hospice enrollment. If strict adher- 
ence to Stage Seven C of the FAST is required before enroll- 
ment, then frequent re-evaluation of non-ordinal patients 
would be necessary or many of these patients would have 
died without benefit of hospice. 
This analysis may underestimate the impact of delay on 
enrollment because it ignores the effect of treatment on sur- 
vival. For the non-ordinal group, even though all were en- 
rolled in hospice, there was a 3-fold difference in survival 
between those who received (14.9 months) and those who did 
not receive (5.2 months) medications for acute illness. This 
finding is similar to the life-prolonging effect of treating fever 
observed by Volicer and his colleagues in those with less 
severe disability.12 This effect of treatment suggests that 
non-ordinal end stage dementia patients, with impaired mo- 
bility and better preserved language, might be suitable for 
hospice if their palliative care plans were conservative and 
not suitable if more life-prolonging care was anticipated. 
In summary, our findings and this discussion would 
support the use of the NHO guidelines for enrolling dementia 
patients. Those individuals who clearly meet the guidelines 
are appropriate for the Medicare hospice benefit, whereas 
those who clearly do not meet the guidelines are not appro- 
priate. Thus the NHO guidelines - when applicable - offer a 
very useful set of criteria for hospice enrollment with eligibil- 
ity for Medicare reimbursement. The problem we have iden- 
tified and tried to address is that of individuals who cannot be 
categorized on the FAST because their progression is not 
ordinal. 
It is possible that with additional iterations, some mod- 
ification of our criteria and/or procedures for dealing with 
individuals who do not progress ordinally on the FAST might 
be shown to define a group of end stage dementia patients 
who fulfill the requirement of dying in 6 months. However, 
one could question this effort and consider alternative ap- 
proaches. When the admission guideline concerning a 
6-months survival time was initially adopted for the Medi- 
care hospice benefit, most hospice patients were dying of 
cancer. The use of this guideline for the new groups of 
patients that hospices have begun to serve, notably dementia 
patients and AIDS patients, may not be appropriate. Al- 
though hospice programs have expanded greatly since their 
inception, only about 15% of terminal patients receive hos- 
pice services annually.22 Alternatives to the Medicare hospice 
benefit have been proposed for patients who are not dying of 
cancer, but at this point hospice care is the only major 
program organized specifically for the needs of dying pa- 
t i e n t ~ . ~ ~  In order to make this important service more acces- 
sible, less rigorous admissions criteria have been suggested 
for AIDS patients, for example, a limited prognosis and a 
need for skilled nursing.24 Similar flexibility may be needed 
for end-stage dementia patients. 
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16. 
APPENDIX 
FUNCTIONAL ASSESSMENT STAGING (FAST, 14) 
(Check highest consecutive level of disability) 
1. No difficulty either subjectively or objectively 
2. Complains of forgetting location of objects. Subjective 
work difficulties 
3. Decreased job functioning evident to co-workers. 
Difficulty in traveling to new locations. Decreased 
organizational capacity* 
4. Decreased ability to perform complex tasks, e.g., 
planning dinner for guests, handling personal finances 
(such as forgetting to pay bills), difficulty marketing, etc 
5. Requires assistance in choosing proper clothing to wear 
for the day, season or occasion, e.g., patients may wear 
the same clothing repeatedly, unless supervised* 
6. A) Improperly putting on clothes without assistance or 
cuing (e.g., may put street clothes on over night 
clothes, or put shoes on wrong feet, or have difficulty 
buttoning clothing) occasionally or more frequently 
over the past weeks* 
B) Unable to bathe properly (e.g., difficulty adjusting 
bath-water temperature) occasionally or more 
frequently over the past weeks* 
C) Inability to handle mechanics of toileting (e.g., 
forgets to flush the toilet, does not wipe properly or 
properly dispose of toilet tissue) occasionally or 
more frequently over the past weeks* 
frequently over the past weeks)* 
over the past weeks)* 
7. A) Ability to speak limited to approximately a half a 
dozen intelligible different words or fewer, in the 
course of an average day or in the course of an 
intensive interview 
intelligible work in an average day or in the course 
of an intensive interview (the person may repeat the 
word over and over) 
C) Ambulatory ability is lost (cannot walk without 
personal assistance) 
D) Cannot sit up without assistance (e.g., the individual 
will fall over if there are not lateral rests (arms) on 
the chair) 
D) Urinary incontinence (occasionally or more 
E) Fecal Incontinence (occasionally or more frequently 
B) Speech ability is limited to the use of a single 
E) Loss of ability to smile 
F) Loss of ability to hold up head independently 
*Scored primarily on the basis of information obtained from a knowledgeable 
informant and/or category. 
